Status:
COMPLETED
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
Microgen LLC
Conditions:
Kidney Stone
Renal Stone
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.
Detailed Description
NGS will be performed on voided urine collected as routine care approximately 30 days prior to surgery. Results will be presented to Infectious Disease pharmacist within 48-72 hours to help select the...
Eligibility Criteria
Inclusion
- Patients planning to undergo kidney or bladder stone removal surgery using endoscopy including ureteroscopy and percutaneous nephrolithotomy or any other transurethral procedure
- Age 18 or older
- Able to give informed consent
Exclusion
- Unwilling or unable to provide informed consent
- Age \< 18
- Does not meet inclusion criteria
Key Trial Info
Start Date :
December 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04404855
Start Date
December 18 2019
End Date
August 31 2022
Last Update
March 12 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Audie Murphy VA Hospital
San Antonio, Texas, United States, 78229
2
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
San Antonio, Texas, United States, 78229
3
University Health System
San Antonio, Texas, United States, 78229